Predicting preference-based utility values using partial proportional odds models

por Ara, Roberta, Kearns, Ben, vanHout, Ben A, Brazier, John E
Publicado 2014

Modelling the cost-effectiveness of combination therapy for early, rapidly progressing rheumatoid arthritis by simulating the reversible and irreversible effects of the disease

por Stephens, Stephanie, Botteman, Marc F, Cifaldi, Mary A, van Hout, Ben A
Publicado 2015

Prevalence and incidence of severe sepsis in Dutch intensive care units

por van Gestel, Aukje, Bakker, Jan, Veraart, Christiaan PWM, van Hout, Ben A
Publicado 2004

Cost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UK

por Clay, Emilie, Jamotte, Aurélien, Verhamme, Peter, Cohen, Alexander T., Van Hout, Ben. A., Gumbs, Pearl.
Publicado 2018

Cross-Sectional Study into the Costs and Impact on Family Functioning of 4-Year-Old Children with Aggressive Behavior

por Raaijmakers, Maartje A., Posthumus, Jocelyne A., van Hout, Ben A., van Engeland, Herman, Matthys, Walter
Publicado 2011

Quantifying Cost-Effectiveness of Controlling Nosocomial Spread of Antibiotic-Resistant Bacteria: The Case of MRSA

por Wassenberg, Marjan W. M., de Wit, G. Ardine, van Hout, Ben A., Bonten, Marc J. M.
Publicado 2010

An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing–Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-...

por Piena, Marjanne A., Kroep, Sonja, Simons, Claire, Fenwick, Elisabeth, Harty, Gerard T., Wong, Schiffon L., van Hout, Ben A.
Publicado 2021

Cost-effectiveness Analysis of Rivaroxaban in the Secondary Prevention of Acute Coronary Syndromes in Sweden

por Begum, Najida, Stephens, Stephanie, Schoeman, Olaf, Fraschke, Anina, Kirsch, Bodo, Briere, Jean-Baptiste, Verheugt, Freek W. A., van Hout, Ben A.
Publicado 2015